Pro Medicus Earnings Estimate

PME Stock   221.75  7.13  3.32%   
By analyzing Pro Medicus' earnings estimates, investors can diagnose different trends across Pro Medicus' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Pro Medicus is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Pro Medicus is projected to generate 0.19 in earnings per share on the 30th of June 2024. Pro Medicus earnings estimates module stress-tests analyst consensus about projected Pro Medicus EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Pro Medicus, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pro Medicus' earnings estimates, investors can diagnose different trends across Pro Medicus' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 128.4 M in 2024
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pro Medicus Earnings per Share Projection vs Actual

About Pro Medicus Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pro Medicus earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pro Medicus estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pro Medicus fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings173.4 M182 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pro Stock Analysis

When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.